Stockscreener 앱 받기
0.5973
5.01%
0.0285
전일 마감가:
$0.5688
열려 있는:
$0.5712
하루 거래량:
83,364
Relative Volume:
0.46
시가총액:
$26.72M
수익:
$80.28M
순이익/손실:
$-38.83M
주가수익비율:
-0.7181
EPS:
-0.8318
순현금흐름:
$-28.67M
1주 성능:
-19.94%
1개월 성능:
-30.60%
6개월 성능:
-60.44%
1년 성능:
-52.22%
1일 변동 폭
$0.5011
$0.6046
1주일 범위
$0.5011
$0.79
52주 변동 폭
$0.5011
$2.20
Tela Bio Inc Stock (TELA) Company Profile
명칭
Tela Bio Inc
전화
484-320-2930
주소
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.5973 | 26.72M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 개시 | Lake Street | Buy |
| 2019-12-03 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | JMP Securities | Mkt Outperform |
| 2019-12-03 | 개시 | Jefferies | Buy |
| 2019-12-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Tela Bio Inc 주식(TELA)의 최신 뉴스
TELA Bio unveils new hernia solution with focus on simplicity and reliability - Traders Union
Aug Fed Impact: Is TELA Bio Inc a stock for growth or value investors2026 AllTime Highs & Safe Entry Trade Signal Reports - baoquankhu1.vn
Q3 2025 TELA Bio Inc Earnings Call Transcript - GuruFocus
Citizens Jmp Issues Pessimistic Forecast for TELA Bio (NASDAQ:TELA) Stock Price - Defense World
Published on: 2026-03-28 00:22:27 - baoquankhu1.vn
TELA Bio, Inc.Common stock - FinancialContent
TELA Bio analysts cut their forecasts after Q4 results - msn.com
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 earnings call transcript - MSN
Citizens cuts Tela Bio stock price target on commercial transition By Investing.com - Investing.com South Africa
Citizens cuts Tela Bio stock price target on commercial transition - Investing.com UK
Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation - MSN
Canaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $2.00 - Defense World
TELA Bio, Inc. (TELA) reports Q4 loss, lags revenue estimates - MSN
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), TELA Bio (TELA) and Nuvalent (NUVL) - The Globe and Mail
EPS Watch: What analysts say about TELA Bio Inc stock2026 Volatility Report & Consistent Income Trade Ideas - baoquankhu1.vn
TELA Bio (NASDAQ:TELA) Given New $1.00 Price Target at Piper Sandler - Defense World
TELA Bio (NASDAQ:TELA) Given New $2.00 Price Target at Lake Street Capital - Defense World
TELA Bio Analysts Cut Their Forecasts After Q4 Results - Benzinga
Patterns Watch: Is TELA Bio Inc showing insider buyingWeekly Profit Analysis & Consistent Profit Trade Alerts - baoquankhu1.vn
TELA Bio 10-K: Revenue $80.3M, Net Loss $38.8M - TradingView
TELA Bio (NASDAQ: TELA) grows 2025 revenue 16% while investing heavily in R&D - Stock Titan
Piper Sandler Lowers Price Target for TELA Bio (TELA) to $1.00 | - GuruFocus
TELA Bio net loss hits USD 9M in Q4 2025 - Medical Buyer
TELA Bio (TELA) Rating Maintained but Price Target Lowered by An - GuruFocus
Piper Sandler cuts TELA Bio stock price target on lowered outlook - Investing.com Canada
Analyst Maintains 'Buy' Rating for TELA, Lowers Price Target to $2.00 | TELA Stock News - GuruFocus
Jefferies cuts TELA Bio stock price target on slower growth outlook - Investing.com UK
TELA Bio, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 Earnings Call Transcript - insidermonkey.com
Jefferies cuts TELA Bio stock price target on slower growth outlook By Investing.com - Investing.com South Africa
TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ... By GuruFocus - Investing.com Canada
TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Rev - GuruFocus
Tela Bio Earnings Call: Growth Momentum, Cautious Outlook - tipranks.com
TELA Bio, Inc. (TELA) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
TELA Bio (TELA) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: TELA Bio Q4 2025 surprises with EPS beat but revenue miss - Investing.com
TelaBio (TELA) Reports Record Quarterly Revenue in Q4 - GuruFocus
TELA Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TELA Bio Q4 Net Loss Narrows, Revenue Rises - marketscreener.com
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
TELA Bio Inc (NASDAQ:TELA) Reports Record Q4 Revenue but Misses Sales Estimates - chartmill.com
TELA Sees Growth with FY26 Revenue Projected to Rise at Least 8% - GuruFocus
TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
TELA Bio Posts Record 2025 Revenue, Sets 2026 Outlook - TipRanks
TELA BIO ($TELA) Releases Q4 2025 Earnings - Quiver Quantitative
Q4 2025 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
TELA Bio (NASDAQ: TELA) lifts 2025 sales 16% but posts $38.8M loss - Stock Titan
TELA Bio, Inc. Provides Revenue Guidance for the First Quarter 2026 and Full Year 2026 - marketscreener.com
TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead O - GuruFocus
If You Invested $1,000 in Tela Bio, Inc. (TELA) - stocktitan.net
Tela Bio Inc (TELA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):